Approval · Notice of Compliance 37564 · 2026
THYCONVI: Notice of Compliance 37564
Issued May 15, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37564
- Date
- May 15, 2026
- Company
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THYCONVI | 02568373 | Marketed |
Medicinal ingredients
- LEVOTHYROXINE SODIUM 20 MCG per ML